Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

March 01, 1989; Volume 35,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Ambler, S K

    1. You have access
      Release of nonmitochondrial sequestered Ca2+ from permeabilized muscle cells in culture.
      S K Ambler and P Taylor
      Molecular Pharmacology March 1989, 35 (3) 369-374;

B

  1. Baur, R

    1. You have access
      The tremorigen aflatrem is a positive allosteric modulator of the gamma-aminobutyric acidA receptor channel expressed in Xenopus oocytes.
      Y Yao, A B Peter, R Baur and E Sigel
      Molecular Pharmacology March 1989, 35 (3) 319-323;
  2. Behrendt, J

    1. You have access
      [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;
  3. Boulay, G

    1. You have access
      Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.
      G Guillemette, S Lamontagne, G Boulay and B Mouillac
      Molecular Pharmacology March 1989, 35 (3) 339-344;
  4. Bristow, M R

    1. You have access
      Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
      M R Bristow, R E Hershberger, J D Port, W Minobe and R Rasmussen
      Molecular Pharmacology March 1989, 35 (3) 295-303;
  5. Brodde, O E

    1. You have access
      [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;

D

  1. Dingledine, R

    1. You have access
      N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
      T A Verdoorn, N W Kleckner and R Dingledine
      Molecular Pharmacology March 1989, 35 (3) 360-368;

E

  1. Eens, A

    1. You have access
      Ketanserin reduces a particular monoamine pool in peripheral tissues.
      J E Leysen, J Wynants, A Eens and P A Janssen
      Molecular Pharmacology March 1989, 35 (3) 375-380;

F

  1. Feldman, R D

    1. You have access
      Beta-adrenergic desensitization reduces the sensitivity of adenylate cyclase for magnesium in permeabilized lymphocytes.
      R D Feldman
      Molecular Pharmacology March 1989, 35 (3) 304-310;

G

  1. Galitzky, J

    1. You have access
      Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
      H Paris, J Galitzky and J M Senard
      Molecular Pharmacology March 1989, 35 (3) 345-354;
  2. Guillemette, G

    1. You have access
      Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.
      G Guillemette, S Lamontagne, G Boulay and B Mouillac
      Molecular Pharmacology March 1989, 35 (3) 339-344;
  3. Guzelian, P S

    1. You have access
      Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
      K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
      Molecular Pharmacology March 1989, 35 (3) 279-285;

H

  1. Haga, K

    1. You have access
      Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
      K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
      Molecular Pharmacology March 1989, 35 (3) 286-294;
  2. Haga, T

    1. You have access
      Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
      K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
      Molecular Pharmacology March 1989, 35 (3) 286-294;
  3. Halm, E

    1. You have access
      Corticosterone increases protein tyrosine kinase activity in the locus coeruleus and other monoaminergic nuclei of rat brain.
      E J Nestler, R Z Terwilliger and E Halm
      Molecular Pharmacology March 1989, 35 (3) 265-270;
  4. Heasley, L E

    1. You have access
      Detection of nerve growth factor and epidermal growth factor-regulated protein kinases in PC12 cells with synthetic peptide substrates.
      L E Heasley and G L Johnson
      Molecular Pharmacology March 1989, 35 (3) 331-338;
  5. Hershberger, R E

    1. You have access
      Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
      M R Bristow, R E Hershberger, J D Port, W Minobe and R Rasmussen
      Molecular Pharmacology March 1989, 35 (3) 295-303;
  6. Hostetler, K A

    1. You have access
      Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
      K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
      Molecular Pharmacology March 1989, 35 (3) 279-285;

I

  1. Ichiyama, A

    1. You have access
      Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
      K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
      Molecular Pharmacology March 1989, 35 (3) 286-294;
  2. Insel, P A

    1. You have access
      [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;

J

  1. Janssen, P A

    1. You have access
      Ketanserin reduces a particular monoamine pool in peripheral tissues.
      J E Leysen, J Wynants, A Eens and P A Janssen
      Molecular Pharmacology March 1989, 35 (3) 375-380;
  2. Johnson, G L

    1. You have access
      Detection of nerve growth factor and epidermal growth factor-regulated protein kinases in PC12 cells with synthetic peptide substrates.
      L E Heasley and G L Johnson
      Molecular Pharmacology March 1989, 35 (3) 331-338;
  3. Joseph, S K

    1. You have access
      The relationship between inositol trisphosphate receptor density and calcium release in brain microsomes.
      S K Joseph and H L Rice
      Molecular Pharmacology March 1989, 35 (3) 355-359;

K

  1. Kangawa, K

    1. You have access
      Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
      K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
      Molecular Pharmacology March 1989, 35 (3) 286-294;
  2. Kleckner, N W

    1. You have access
      N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
      T A Verdoorn, N W Kleckner and R Dingledine
      Molecular Pharmacology March 1989, 35 (3) 360-368;

L

  1. Lamontagne, S

    1. You have access
      Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.
      G Guillemette, S Lamontagne, G Boulay and B Mouillac
      Molecular Pharmacology March 1989, 35 (3) 339-344;
  2. Levin, W

    1. You have access
      Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
      K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
      Molecular Pharmacology March 1989, 35 (3) 279-285;
  3. Leysen, J E

    1. You have access
      Ketanserin reduces a particular monoamine pool in peripheral tissues.
      J E Leysen, J Wynants, A Eens and P A Janssen
      Molecular Pharmacology March 1989, 35 (3) 375-380;

M

  1. Manganiello, V C

    1. You have access
      Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes.
      C J Smith and V C Manganiello
      Molecular Pharmacology March 1989, 35 (3) 381-386;
  2. Matsuo, H

    1. You have access
      Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
      K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
      Molecular Pharmacology March 1989, 35 (3) 286-294;
  3. Michel, M C

    1. You have access
      [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;
  4. Minobe, W

    1. You have access
      Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
      M R Bristow, R E Hershberger, J D Port, W Minobe and R Rasmussen
      Molecular Pharmacology March 1989, 35 (3) 295-303;
  5. Mitsuhashi, M

    1. You have access
      Receptor glycosylation regulates the affinity of histamine H1 receptors during smooth muscle cell differentiation.
      M Mitsuhashi and D G Payan
      Molecular Pharmacology March 1989, 35 (3) 311-318;
  6. Molowa, D T

    1. You have access
      Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
      K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
      Molecular Pharmacology March 1989, 35 (3) 279-285;
  7. Motulsky, H J

    1. You have access
      [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;
  8. Mouillac, B

    1. You have access
      Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.
      G Guillemette, S Lamontagne, G Boulay and B Mouillac
      Molecular Pharmacology March 1989, 35 (3) 339-344;

N

  1. Nestler, E J

    1. You have access
      Corticosterone increases protein tyrosine kinase activity in the locus coeruleus and other monoaminergic nuclei of rat brain.
      E J Nestler, R Z Terwilliger and E Halm
      Molecular Pharmacology March 1989, 35 (3) 265-270;

P

  1. Paris, H

    1. You have access
      Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
      H Paris, J Galitzky and J M Senard
      Molecular Pharmacology March 1989, 35 (3) 345-354;
  2. Payan, D G

    1. You have access
      Receptor glycosylation regulates the affinity of histamine H1 receptors during smooth muscle cell differentiation.
      M Mitsuhashi and D G Payan
      Molecular Pharmacology March 1989, 35 (3) 311-318;
  3. Peter, A B

    1. You have access
      The tremorigen aflatrem is a positive allosteric modulator of the gamma-aminobutyric acidA receptor channel expressed in Xenopus oocytes.
      Y Yao, A B Peter, R Baur and E Sigel
      Molecular Pharmacology March 1989, 35 (3) 319-323;
  4. Politi, P M

    1. You have access
      Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
      P M Politi and B K Sinha
      Molecular Pharmacology March 1989, 35 (3) 271-278;
  5. Port, J D

    1. You have access
      Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
      M R Bristow, R E Hershberger, J D Port, W Minobe and R Rasmussen
      Molecular Pharmacology March 1989, 35 (3) 295-303;

R

  1. Rasmussen, R

    1. You have access
      Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
      M R Bristow, R E Hershberger, J D Port, W Minobe and R Rasmussen
      Molecular Pharmacology March 1989, 35 (3) 295-303;
  2. Rice, H L

    1. You have access
      The relationship between inositol trisphosphate receptor density and calcium release in brain microsomes.
      S K Joseph and H L Rice
      Molecular Pharmacology March 1989, 35 (3) 355-359;

S

  1. Schnepel, B

    1. You have access
      [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;
  2. Senard, J M

    1. You have access
      Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
      H Paris, J Galitzky and J M Senard
      Molecular Pharmacology March 1989, 35 (3) 345-354;
  3. Sigel, E

    1. You have access
      The tremorigen aflatrem is a positive allosteric modulator of the gamma-aminobutyric acidA receptor channel expressed in Xenopus oocytes.
      Y Yao, A B Peter, R Baur and E Sigel
      Molecular Pharmacology March 1989, 35 (3) 319-323;
  4. Sinha, B K

    1. You have access
      Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
      P M Politi and B K Sinha
      Molecular Pharmacology March 1989, 35 (3) 271-278;
  5. Smith, C J

    1. You have access
      Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes.
      C J Smith and V C Manganiello
      Molecular Pharmacology March 1989, 35 (3) 381-386;

T

  1. Taylor, P

    1. You have access
      Release of nonmitochondrial sequestered Ca2+ from permeabilized muscle cells in culture.
      S K Ambler and P Taylor
      Molecular Pharmacology March 1989, 35 (3) 369-374;
  2. Terwilliger, R Z

    1. You have access
      Corticosterone increases protein tyrosine kinase activity in the locus coeruleus and other monoaminergic nuclei of rat brain.
      E J Nestler, R Z Terwilliger and E Halm
      Molecular Pharmacology March 1989, 35 (3) 265-270;
  3. Thomas, P E

    1. You have access
      Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
      K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
      Molecular Pharmacology March 1989, 35 (3) 279-285;
  4. Tschada, R

    1. You have access
      [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;

U

  1. Uchiyama, H

    1. You have access
      Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
      K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
      Molecular Pharmacology March 1989, 35 (3) 286-294;

V

  1. Verdoorn, T A

    1. You have access
      N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
      T A Verdoorn, N W Kleckner and R Dingledine
      Molecular Pharmacology March 1989, 35 (3) 360-368;

W

  1. Wrighton, S A

    1. You have access
      Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
      K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
      Molecular Pharmacology March 1989, 35 (3) 279-285;
  2. Wynants, J

    1. You have access
      Ketanserin reduces a particular monoamine pool in peripheral tissues.
      J E Leysen, J Wynants, A Eens and P A Janssen
      Molecular Pharmacology March 1989, 35 (3) 375-380;

Y

  1. Yao, Y

    1. You have access
      The tremorigen aflatrem is a positive allosteric modulator of the gamma-aminobutyric acidA receptor channel expressed in Xenopus oocytes.
      Y Yao, A B Peter, R Baur and E Sigel
      Molecular Pharmacology March 1989, 35 (3) 319-323;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 35, Issue 3
1 Mar 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics